Randomised feasibility study to compare the use of Therabite® with wooden spatulas to relieve and prevent trismus in patients with cancer of the head and neck. by Lee, R et al.
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bstract
ur aim was to compare the efficacy of the Therabite® jaw motion rehabilitation system (Atos Medical) with that of wooden spatulas to
elieve and prevent trismus in patients who have had radiotherapy for stage three and four oral and oropharyngeal cancer. Secondary aims
ere to assess the feasibility and the impact of exercise on health-related quality of life (QoL), and the use of health services after treatment.
e designed a randomised, open-label, controlled, three-centre feasibility study to compare the effectiveness and cost of the Therabite® and
ooden spatulas. We studied compliance with exercises and health-related QoL, assessed cost using three health economics measures, and
onducted semistructured interviews with patients. Patients were randomised into two groups: the Therabite® group (n = 37) and the wooden
patula group (n = 34). All patients had some sense of jaw tightening before the study started. Mean mouth opening after six months increased
n both groups, but the difference between the groups was not significant (p = 0.39). Completion rates for the three economic measures were
ood. There was no significant difference between the two groups in frequency of contact with care services or in QoL. Exercises during and
fter radiotherapy can ameliorate trismus in patients with stage three and four oral and oropharygeal cancers, but differences between groups
n efficacy, compliance, QoL, or use of hospital or community health services, were not significant.
 2018 The Authors. Published by Elsevier Ltd on behalf of The British Association of Oral and Maxillofacial Surgeons. This is an open
ccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ntroduction
round 7600 patients were diagnosed with cancer of the lip,
ral cavity, or oropharynx in the UK in 2013. Trismus, which
an develop as a result of the disease or its treatment, is under-
eported as a serious complication,1 and radiotherapy is been
eported as one of the most common causes. The definition
sh Association of Oral and Maxillofacial Surgeons. This is an open access
c-nd/4.0/).
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f trismus by Dijkstra et al as a maximum mouth opening of
5 mm or less is now widely accepted.2 Trismus can impair
he ability to chew, swallow, and speak, and can be detri-
ental to oral health, dental integrity, and overall quality
f life (QoL).3–6 Psychological difficulties can include low
elf-esteem, depression, and suicidal tendencies.7
Studies by van der Molen et al and and Carnaby-Mann
t al on jaw exercises in patients treated with chemoradio-
herapy for cancer of the head and neck showed less of a
ecline in mouth opening than standard rehabilitation tech-
iques after treatment. However, both studies were small
ith only a 10-week follow up, and there were no eco-
omic evaluations.8,9 Current treatments such as the use of
ooden spatulas, Therabite® (Atos Medical), Dynasplint®
Dynasplint Systems Inc), and swallowing therapies, have
hown only a modest effect once trismus is established.10–14
owever, Scherpenhuizen et al suggested that jaw exercises
an improve mouth opening in patients with established
adiotherapy-induced trismus.12 In view of these conflicting
pinions, there is consensus about the need for a rigorous,
ontrolled study to provide clearer evidence of the value of
xercise devices in patients who have trismus before radio-
herapy or who have a high risk of developing it afterwards.10
This feasibility study was designed to find out whether
xercises are beneficial and to inform the design of a larger
tudy, in line with the Medical Research Council framework
or complex interventions.15
Our main aim was to compare the efficacy of the
herabite® with that of the current standard treatment with
ooden spatulas to relieve or prevent trismus. Secondary
ims were to assess the feasibility and the impact of exer-
ise on health-related QoL, the need for additional treatment,
nd completion rates of three health economics outcome
easures: the Client Service Receipt Inventory (CSRI),
Q-5D-3L (EuroQol), and ICECAP-A (ICEpop CAPability
easure for Adults).
aterial  and  methods
his randomised, open-label, controlled, three-centre feasi-
ility study was designed to compare the use of Therabite®
ith wooden spatulas to treat and relieve trismus in patients
ith stages three and four oral and oropharyngeal cancer. The
tudy was approved by the North Manchester Ethics Com-
ittee (12/NW/0414) and all patients gave written informed
onsent before the study started.
Patients treated by primary chemoradiotherapy, radio-
herapy, or operation followed by chemoradiotherapy or
adiotherapy, were recruited from three tertiary referral cen-
res in England. Those who had tightening of the jaw before
adiotherapy were invited to participate. They were all pre-
cribed a dose of 60-70 Gy in 30-35 fractions to the jaw over
ix to seven weeks using intensity-modulated radiotherapy
IMRT).
h
p
cillofacial Surgery 56 (2018) 283–291
To detect a minimum mean (SD) difference in mouth
pening of 5 (8) mm from baseline (previously estimated
rom patients who had radiotherapy without operation) with
0% power, required 42 patients/group. With a predicted 25%
ttrition rate, 112 patients were required in total.
Patients were randomised using the minimisation method
ith a random element (allocation was with a 0.75 probability
o the arm yielding a lower imbalance score or 0.5 if scores
ere tied). Controlled factors were operation or no operation,
entre, and synchronous chemotherapy given or not given.
atients were then instructed to do their exercises according
o a set protocol.
Those whose mouth opening was less than 12 mm (not
ide enough for the Therabite® ), or who were anatomically
nable to use the Therabite® because they were partially den-
ate, and those with a past history of operation or radiotherapy
o the head and neck, were excluded.
rotocol  for  use  of  Therabite® or  wooden  spatula  and
easurement of  mouth  opening
atients randomised to either group were asked to follow the
-5-30 protocol, which comprised five sessions/day for six
onths. At each session they had to open their mouths for
0 seconds then close it. They had to do this five times.16,17
hey started the exercises about three weeks postoperatively
r one to three weeks before radiotherapy, and recorded the
aximum mouth opening at the end of each day using a
laton Therabite® range of motion scale (Atos Medical) to
how compliance. They also used a Willis bite gauge to mea-
ure from the bottom of the nose to the chin with the mouth
losed and open at baseline and again three and six months
fter treatment.
Table 1 shows the patients’ details.
uality  of  life
uality of life (QoL) was assessed at baseline, and at three and
ix months after treatment using the European Organisation
or Research and Treatment of Cancer Quality of Life Ques-
ionnaire (EORTC QLQ-C 30) and the Head and Neck (H&N)
odule (EORTC QLQ H&N 35).18 Data were collected on
 pro forma.
ealth  economics  assessments
o assess health economics we used the EQ-5D-3L (Euro-
ean Quality of Life - 5 Dimensions -3 Levels) at baseline
nd three and six months after treatment.19 This is a validated,
eneric, health-related, preference-based measure that com-
rises five domains: mobility; self-care; usual activities; pain
nd discomfort; and anxiety and depression. Each domain
as three levels (no problem, some problems, and major
roblems) giving a total of 243 possible health states.20 We
onverted these into EQ-5D-3L index scores (single utility
R. Lee et al. / British Journal of Oral and Max
Table 1
Baseline characteristics of patients.
Wooden spatulas Therabite®
Centre:
Liverpool 10 12
Birmingham 1 3
Manchester 23 22
Operation:
No 14 11
Yes 20 26
Chemoradiation:
No 9 14
Yes 25 23
Sex:
Male 24 25
Female 10 12
Alcohol use:
Current heavy 4 2
Previous heavy 8 16
Never heavy 22 19
Smoking status:
Current smoker 4 4
Ex smoker 17 25
Never smoked 13 8
Site of disease:
Oral 11 15
Oropharyngeal 23 22
Stage:
T1/2 N+ M0 14 16
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MT3/4 N0 M0 5 4
T3/4 N+ M0 15 17
cores anchored at 0 for death and one for perfect health),
hich can be “negative” if patients consider their health to
e worse than death.20,21 We then translated the index scores
nto quality-adjusted life years (QALY) by weighting them
ith quantity of life (the aggregated number of years lived),
sing the area-under-the-curve method.22,23 Quality-adjusted
ife years is a common unit of effect (a measure of utility)
hat has been advocated by the National Institute for Health
nd Care Excellence (NICE) in the UK for the evaluation of
ost-effectiveness.24
ICECAP-A (ICEpop CAPability measure for Adults)
baseline, and at three and six months) is a measure of QoL
ith five domains: attachment, security, role, enjoyment, and
ndependence.25
At three and six months we interviewed patients using the
lient Service Receipt Inventory (CSRI) to find out how often
hey had used primary and secondary care services26 such as
peech and language therapy; dietary and nutritional advice
r artificial feeding, or both, and orthodontic interventions
ncluding surgery.
ested  qualitative  study
e used semistructured telephone interviews up to six
onths after completion of the study to find out about theatients’ experiences of the study and how trismus affected
heir daily lives. To plan possible variables for a future phase
II trial, patients were asked about compliance with the pro-
p
o
billofacial Surgery 56 (2018) 283–291 285
ocol and whether pain had affected it. Data were transcribed
erbatim and were analysed according to the framework anal-
sis reported by Ritchie and Spencer.27
ata  analysis
tatistical analysis was done with the help of Stata statistical
oftware, release 13 (StataCorp LP, College Station, USA)
nd SPSS for Windows, version 16 (SPSS Inc, Chicago,
SA). The null hypothesis for the primary analysis was
hat there would be no difference between the groups in the
mount of mouth opening at six months.
Descriptive statistics were used to report the prevelence of
rismus and mouth opening. Similarly descriptive statistics
ere used to calculate the number of patients who completed
ifferent parts of the study and the amount of missing data.
The original power calculation was based on a t  test of
hange in scores, but the analysis of covariance (ANCOVA)
s more efficient. An ANCOVA model was fitted with the six-
onth measurement of mouth opening as the response, and
he trial arm as the variable of primary interest after adjust-
ents had been made for baseline, centre, operation, and
hemoradiation.
Economic analysis was done using Microsoft Excel 2013
nd SPSS Statistics for Windows, version 22 (IBM Corp,
rmonk, USA). Confidence intervals (CI) for costs and
ealth-related QoL were estimated using non-parametric
ootstrapping methods.28,29 A simulation of 5000 non-
arametric bootstrapping iterations was run to construct 95%
I around estimates of costs and QoL scores using Microsoft
xcel 2013.
esults
f the 237 patients screened, 71 were included. Most of those
ot included had had no subjective tightening of the jaw or
ad declined participation.
There were 37 patients in the Therabite® group and 34 in
he wooden spatula group (Fig. 1). Median (range) maximum
outh opening at baseline was 24.0 (12.0-58.0) mm for the
herabite® group and 21.8 (12.5–48.0) mm for the spatula
roup. Recorded baseline characteristics (age, sex, previous
peration, radiotherapy or chemoradiotherapy, site and stage
f disease, use of alcohol, and smoking status) were broadly
imilar in both groups. This was made possible by using pri-
ri stratification factors to minimise differences at baseline
Table 1).
aximum  mouth  opening
easurements of mouth opening at six months were sup-
lied by 41/71 participants, which may indicate that mouth
pening in both groups had not deteriorated. The difference
etween the two interventions was not significant although
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Fig. 1. Consort diagram.
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Table 2
Contacts with primary and secondary care health services by 30 participants six months after baseline.
Therabite (n = 16) Wooden spatula (n = 14) Mann Whitney
Total; mean, median (range) Total; mean, median (range) p valuea
NHS primary care:
Cancer nurse 10; 0.63, 0 (0-4) 6; 0.43, 0 (0-6) 0.313
General practitioner 51; 3.19, 2 (0-13) 32; 2.29, 2 (0-5) 0.697
Practice nurse 25; 1.56, 0 (0-14) 7; 0.50, 0 (0-3) 0.637
Community nurse 128; 8.00, 1 (0-56) 47; 3.36, 1 (0-22) 0.667
Physiotherapist 2; 0.13, 0 (0-2) 18; 1.29, 0 (0-9) 0.294
Speech and language therapist 43; 2.69, 2 (0-14) 36; 2.57, 2 (0-9) 1.000
Occupational health therapist 0 0 1.000
Dietician 41; 2.56, 1 (0-16) 51; 3.64, 2 (0-11) 0.637
Other healthcare professional 81; 5.06, 1 (0-52) 28; 2.00, 1 (0-10) 0.667
NHS secondary care:
Oncology inpatient ward (bed days) 256; 16.06, 9 (0-78) 217; 15.50, 6 (0-74) 0.790
Medical inpatient ward (bed days) 31; 1.94, 0 (0-14) 51; 3.64, 0 (0-30) 0.854
Intensive care inpatient ward (bed days) 0 0 1.000
Other inpatient ward (bed days) 6; 0.38, 0 (0-6) 0 0.790
Physiotherapist inpatient consultation 62; 3.88, 0 (0-55) 3; 0.21, 0 (0-2) 1.000
Speech and language therapist inpatient consultation 4; 0.25, 0 (0, 2) 4; 0.29, 0 (0, 2) 0.918
Dietician inpatient consultation 56; 3.50, 1 (0, 25) 38; 2.71, 1 (0, 20) 0.822
Occupational health therapist inpatient consultation 2; 0.13, 0 (0, 2) 0; 0.00, 0 (0, 0) 0.790
Other inpatient consultation 3; 0.19, 0 (0, 2) 0; 0.00, 0 (0, 0) 0.580
Outpatient visits 76; 4.75, 1 (0, 30) 74; 5.29, 1 (0, 58) 1.000
Accident and emergency 1; 0.06, 0 (0, 1) 18; 1.29, 0 (0, 12) 0.154
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pa Significant at 5% significance level.
he power of the study was low because we failed to achieve
he target recruitment and the attrition rate was higher than
nticipated. The estimated difference in mean mouth opening
t six months after adjustment for baseline, centre, operation,
nd chemoradiation in an analysis of covariance model was
2.43 mm (95% CI -8.15 to 3.29). This was not significant
t35 = -0.86, 2-tail p = 0.39). There was no formal evidence
gainst two key assumptions of the fitted model: normality
f the residuals (Shapiro-Wilk W test, Z = 0.6, 1-tail p = 0.27)
nd homogeneity of variance (Cook-Weisberg test for het-
roskedasticity, X52 = 7.90, 1-tail p = 0.16)
Compliance with the exercises was poor, particularly at the
nd of radiotherapy, but there were no appreciable differences
etween the groups (data obtained from the patients’ logs).
ealth-related  QoL
ubscales (taken from the EORTC QLC-C30) related to eat-
ng, weight loss, pain, and mouth opening, were predicted
o be more sensitive to changes than others in patients with
rismus. However, there was no appreciable difference in the
hange in mean scores from baseline to six months between
roups for any of these items.
elephone  interviews
elephone interviews were designed to explore the conse-
uences and possible effects of the exercises on pain and
ompliance with the exercises as well as their nature, accept-
bility, and impact in terms of motivation and perceived
a
lmprovement in mouth opening. Of the 15 patients inter-
iewed, some had complied and some had not during the
hree and six-month follow-up periods, but compliance in the
herabite® group seemed better at both time points. Patients
elt they had to stop or do fewer exercises towards the end of
he course of radiotherapy until roughly four weeks after it
ad stopped because of painful mucositis. They began again
hen the side effects had abated.
Key feasibility and acceptability messages were: change
he wording of the exercise regimen to at “least three times
 day” rather than five times a day; stop doing the exer-
ises when the side effects of radiotherapy are at their worst;
ontact healthcare professionals more regularly.
ealth  economics  assessments
ompletion rates (at baseline, and at three and six months) of
he three health economics measures were: CSRI: 89%, and
00%, at three and six months, respectively; EQ-5D-3L: 90%,
8%, and 87%, respectively; and ICECAP-A: 59%, 49%, and
4%, respectively. Across the time points, overall completion
ates were 95%, 85% and 61% for the CSRI, EQ-5D-3L and
CECAP-A, respectively.
Although it was not a core feasibility objective, we also
ade an exploratory analysis of the cost consequences (from
he perspective of the NHS) of the participants who had com-
lete cost and outcome data (n = 30) (Tables 2–5).Table 2 shows the number of contacts with primary
nd secondary care health services six months after base-
ine. Differences between the groups were not significant.
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Table 3
Mean (SD) costs (£) of all contacts with NHS primary and secondary care services by participants over the six-month follow-up period.
Therabite (n = 16) Wooden spatula (n = 14) Mean difference in £
(bootstrapped 95%CI)
NHS primary care:
Cancer nurse 60.47 (139.12) 38.57 (144.32) 21.90
General practitioner 188.91 (210.35) 190.82 (194.58) -1.91
Practice nurse 18.22 (34.96) 11.99 (26.24) 6.23
Community nurse 307.66 (704.63) 113.14 (223.99) 194.52
Physiotherapist 4.50 (18.00) 27.85 (56.46) -23.35
Speech and language therapist 45.56 (47.64) 46.93 (48.14) -1.37
Occupational health therapist 0.00 (0.00) 0.00 (0.00) 0.00
Dietician 37.77 (49.38) 95.58 (122.89) -57.81
Other healthcare professional 172.48 (316.27) 135.57 (246.80) 36.91
Total cost NHS primary care 835.56 (974.13) 660.46 (637.13) 175.10 (-358.51 to 759.77)
NHS secondary care:
Oncology inpatient ward 9678.00 (12783.29) 9001.93 (12641.66) 676.07
Medical inpatient ward 1110.19 (2532.19) 2087.36 (4797.26) -977.17
Intensive care inpatient ward 0.00 (0.00) 0.00 (0.00) 0.00
Other inpatient ward 120.75 (483.00) 0.00 (0.00) 120.75
Physiotherapist inpatient consultation 164.00 (579.91) 10.43 (27.76) 153.57
Speech and language therapist inpatient
consultation
24.13 (54.54) 27.57 (57.71) -3.44
Dietician inpatient consultation 216.19 (388.57) 169.14 (316.15) 47.05
Occupational health therapist inpatient
consultation
8.50 (34.00) 0.00 (0.00) 8.50
Other inpatient consultation 16.94 (48.06) 0.00 (0.00) 16.94
Outpatient visits 513.56 (1000.97) 466.29 (1205.24) 47.27
Accident and emergency 6.56 (26.23) 134.88 (332.85) -128.32
Total cost NHS secondary care 11858.81 (14055.02) 11897.60 (13421.63) -38.79 (-9463.46 to 9446.84)
Total cost NHS primary and secondary care 12694.37 (14136.93) 12558.06 (13675.36) 136.31 (-9419.24 to 9791.03)
Intervention cost (intervention – Therabite and
control – wooden spatula)
251.94 (0.00) 2.84 (0.00) 249.10
Total cost 12946.31 (14136.93) 12560.90 (13675.36) 385.41 (-8916.37 to 10013.82)
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able 3 shows the mean costs of all contacts with NHS
rimary and secondary care services over the same period.
he Therabite® intervention cost £251.94/patient compared
ith £2.84/patient for wooden spatulas. The mean (SD) total
ost/patient was £12 946 (£14 137) in the Therabite® group
nd £12 561 (£13 675) in the spatula group (£385 more in
he Therabite® group; bootstrapped 95% CI: -£8916 to £10
14).
Table 4 shows mean EQ-5D-3L index scores, mean (SD)
uality-adjusted life years (QALY) and incremental mean
SD) QALY between the groups over the six-month period.
Change in mean ICECAP-A index scores between study
ime points and the difference in change in the mean ICECAP-
 index scores between groups over the six-month study
eriod were assessed for 19 of the 30 participants who had
omplete ICECAP-A data (Table 5).
iscussion recent systematic review has shown that exercises with
evices to mobilise the jaw after treatment yield better results
han no exercise in patients with radiotherapy-induced tris-
a
b
mus after treatment for cancer of the head and neck.12
ur study has shown that exercises with the Therabite® or
ooden spatulas, before, during, and after radiotherapy, can
elieve radiation-induced trismus in this group. Melchers
t al described an increase in mouth opening when patients
id the exercises more often.30 The authors also found that
elf-discipline and clearly-set objectives were important for
aintaining the necessary effort. The main factor that neg-
tively affected adherence was painful mucositis, as in our
tudy. Other factors, such as anxiety, ill-fitting Therabite®
ads, and failure to set goals during treatment, also had a neg-
tive effect. Tang et al showed that rehabilitation training can
low down the progress of trismus in patients with nasopha-
yngeal carcinoma after radiotherapy.31 Several studies have
hown that use of a Therabite® was no more effective than use
f wooden spatulas or active range-of-motion exercises.32,33
owever, Pauli et al reported that mouth opening increased
ore after use of a Therabite® than after use of the Engström
evice (a wooden clothespeg with an attached rubber band),
34lthough compliance was comparable. An earlier study
y Buchbinder et al also showed that the Therabite® was
ore efficient than unassisted stretching or stretching using
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Table 4
Mean (SD) EQ-5D-3L index scores, mean (SD) quality-adjusted life years (QALY) and incremental mean (SD) QALY six months after baseline.
Therabite (n = 16) Wooden spatula (n = 14) Incremental mean
QALY between
groupsa (bootstrapped
95% CI)
Baseline 3 months 6 months QALY over 6
months
Baseline 3 months 6 months QALY over 6
months
EQ-5D-3L index 0.6914
(0.1863)
0.6209
(0.2806)
0.6935
(0.2523)
0.3283
(0.1082)
0.6232
(0.3599)
0.6824
(0.2999)
0.7481
(0.1844)
0.3420
(0.1330)
-0.0137 (-0.0978 to
0.0706)
a Incremental mean QALY between groups = mean QALY for intervention group minus mean QALY for control group.
Table 5
Mean (SD) ICECAP-A capability index scores, change in mean ICECAP-A index score between study time points and difference in mean (SD) change in scores between groups six months after baseline
(n = 19/30).b
Therabite® (n = 8)b Wooden spatula (n = 11)b Difference in mean
change scores between
groupsa (bootstrapped
95% CI)
Baseline 3 months 6 months Change in mean
score between
baseline and 6
months
Baseline 3 months 6 months Change in mean
score between
baseline and 6
months
ICECAP-A capability
index scores
0.8733
(0.1092)
0.8095
(0.1967)
0.8551
(0.1209)
-0.0182 (0.0873) 0.8914
(0.1524)
0.9175
(0.0927)
0.9079
(0.1506)
0.0165 (0.2029) -0.0347 (-0.1726 to
0.0828)
a Difference in mean change scores between groups = (Mean change score for intervention) minus (Mean change score for control).
b ICECAP-A analysis was conducted on 19 out of 30 participants who had complete ICECAP-A data (n = 8 Therabite® group, n = 11 wooden spatula group).
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ooden spatulas, although it included only a small number
f patients.35
imitations  of  the  study
atients who felt a tightening of the jaw before radiotherapy
ere included in the study, but those in whom it may have
eveloped during treatment were omitted. This could be con-
idered in a more adaptive study design such as a stepped
edge design in which patients would be randomised as soon
s the jaw tightened.
A larger group of patients and more study-specific follow
p may have provided more representative data on both the
uantitative and qualitative aspects of the study. Telephone
nterviews with a larger group of patients would have pro-
ided additional information about the problems they face.
atients’ suggestions to alter the exercise regimen to “up to
ve times a day”, when exercises were more likely to be
one three times a day, have not been validated. A dose-
ffect analysis of a new protocol would be required in future
tudies.
The attrition rate for this study, which was set at 25% as
n other head and neck cancer toxicity intervention studies,
as higher than we expected. This could have been caused
y the demands of the prescribed exercise regimen and the
ifficulty of complying in the presence of severe mucositis.
It would be useful to use a more sensitive scale such as
he Gothenburg Trismus Questionnaire to measure trismus-
pecific symptoms in a full-scale trial, as it can be used to track
hanges in symptoms.36 Unfortunately it was not available
t the start of our study.
To the best of our knowledge, this is the first study to pro-
ide a exercise regimen before radiotherapy, and to include a
ealth economics aspect within the design to enable health-
are professionals make evidence-based decisions about
reatment and use of resources. The overall response rates for
ll the health economics measures were good. In line with a
tudy by Clarke et al, our findings show that it is feasible
o collect information about health economics in a definitive
andomised trial in this group.37
In conclusion, this feasibility study has shown that mouth
pening had generally increased in both groups, and that exer-
ises during and after radiotherapy can relieve trismus in these
atients.
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